Pharma and Biotech
Date | Broker name | New | Price | Old price target | New price target | Broker change |
---|---|---|---|---|---|---|
04-Sep-24 | Deutsche | Buy | 140.80p | - | 190.00p | Reiteration |
03-Sep-24 | Berenberg Bank | Buy | 128.10p | - | 282.00p | Reiteration |
03-Jul-24 | Berenberg Bank | Buy | 102.40p | 350.00p | 282.00p | Reiteration |
28-Jun-24 | RBC Capital Markets | Outperform | 94.40p | - | 260.00p | Reiteration |
23-May-24 | JP Morgan Cazenove | Overweight | 111.10p | - | - | Reiteration |
17-Apr-24 | Berenberg Bank | Buy | 98.90p | - | 350.00p | Reiteration |
12-Apr-24 | Citigroup | Buy | 107.00p | - | 210.00p | Reiteration |
16-Nov-23 | JP Morgan Cazenove | Overweight | 198.80p | - | - | Reiteration |
13-Nov-23 | RBC Capital Markets | Outperform | 197.80p | 350.00p | 300.00p | Reiteration |
07-Sep-23 | Barclays | Overweight | 218.40p | - | 355.00p | Reiteration |
01-Aug-23 | Berenberg Bank | Buy | 259.80p | - | 529.00p | Reiteration |
07-Jun-23 | Citigroup | Buy | 264.40p | - | 390.00p | Reiteration |
26-May-23 | Berenberg Bank | Buy | 262.40p | - | 529.00p | Reiteration |
17-Apr-23 | Berenberg Bank | Buy | 228.80p | - | 529.00p | Reiteration |
23-Mar-23 | JP Morgan Cazenove | Overweight | 201.00p | 460.00p | 390.00p | Reiteration |
22-Mar-23 | Berenberg Bank | Buy | 197.80p | - | 529.00p | Reiteration |
07-Feb-23 | Barclays | Overweight | 238.50p | 420.00p | 400.00p | Reiteration |
17-Oct-22 | RBC Capital Markets | Outperform | 267.00p | 400.00p | 400.00p | Reiteration |
11-Oct-22 | JP Morgan Cazenove | Overweight | 250.00p | - | - | Reiteration |
16-Sep-22 | Berenberg Bank | Buy | 289.00p | 671.00p | 671.00p | Reiteration |
08-Aug-22 | Berenberg Bank | Buy | 312.50p | 671.00p | 671.00p | Reiteration |
08-Aug-22 | RBC Capital Markets | Outperform | 312.50p | 400.00p | 400.00p | Reiteration |
06-Jul-22 | Berenberg Bank | Buy | 310.00p | 671.00p | 671.00p | Reiteration |
06-Jul-22 | RBC Capital Markets | Outperform | 310.00p | 400.00p | 400.00p | Reiteration |
08-Jun-22 | Berenberg Bank | Buy | 363.00p | - | 671.00p | Reiteration |
31-May-22 | Barclays | Overweight | 322.00p | 700.00p | 500.00p | Reiteration |
20-May-22 | Berenberg Bank | Buy | 322.50p | - | 671.00p | Reiteration |
09-May-22 | RBC Capital Markets | Outperform | 257.50p | 400.00p | 400.00p | Reiteration |
29-Mar-22 | JP Morgan Cazenove | Overweight | 407.00p | 790.00p | 710.00p | Reiteration |
24-Mar-22 | RBC Capital Markets | Outperform | 423.00p | - | 700.00p | Reiteration |
17-Mar-22 | Berenberg Bank | Buy | 440.00p | 662.00p | 662.00p | Reiteration |
15-Mar-22 | Barclays | Overweight | 389.00p | 700.00p | 700.00p | Reiteration |
04-Feb-22 | RBC Capital Markets | Outperform | 502.00p | - | 750.00p | Reiteration |
03-Feb-22 | Berenberg Bank | Buy | 497.50p | 662.00p | 662.00p | Reiteration |
12-Jan-22 | JP Morgan Cazenove | Overweight | 554.00p | - | - | Reiteration |
10-Jan-22 | RBC Capital Markets | Outperform | 565.00p | 800.00p | 750.00p | Reiteration |
04-Jan-22 | JP Morgan Cazenove | Overweight | 671.00p | 725.00p | 790.00p | Reiteration |
16-Dec-21 | Barclays | Overweight | 711.00p | - | 700.00p | Reiteration |
03-Dec-21 | Berenberg Bank | Buy | 670.00p | - | 662.00p | Reiteration |
02-Dec-21 | RBC Capital Markets | Outperform | 688.00p | 800.00p | 800.00p | Reiteration |
19-Nov-21 | RBC Capital Markets | Outperform | 692.00p | 800.00p | 800.00p | Reiteration |
10-Nov-21 | JP Morgan Cazenove | Overweight | 591.00p | - | 725.00p | New Coverage |
10-Nov-21 | Barclays | Overweight | 591.00p | - | 700.00p | New Coverage |
10-Nov-21 | Berenberg Bank | Buy | 591.00p | - | 662.00p | New Coverage |
10-Nov-21 | RBC Capital Markets | Outperform | 591.00p | - | 800.00p | New Coverage |
Currency | UK Pounds |
Share Price | 153.40p |
Change Today | -2.80p |
% Change | -1.79 % |
52 Week High | 224.40 |
52 Week Low | 86.55 |
Volume | 732,761 |
Shares Issued | 941.46m |
Market Cap | £1,444.19m |
Beta | 0.00 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:35 | 384,753 @ 153.40p |
16:35 | 1,610 @ 153.40p |
16:35 | 2,324 @ 153.40p |
16:35 | 681 @ 153.40p |
16:35 | 383 @ 153.40p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Nick Keher |
You are here: research